Not finding it? Sign in to also search OpenAlex live.
-
Multi-Modal Monitoring and Modelling of Extreme Hydro-Geomorphological Events: Bridging the Gap Between Local Dynamics and Catchment-Scale Predictions2026 conference-abstract Environmental Science Hydrology and Sediment Transport Processes Open access
Anette Eltner, Michael Dietze, Julia Kowalski, Jochen Aberle, Jens Grundmann, Bernhard Vowinckel
0citations -
P0117 Fibroblast activation protein is selectively expressed by CD90+ fibroblasts in inflammatory bowel disease-associated intestinal fibrosis2026 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Dalia A. Lartey, Bram W. van Os, B J Ke, Kelly van Wijnbergen, G De Hertogh, Marieke C. Barnhoorn, +7 more
0citations -
OP15 High-definition white light endoscopy with segmental re-inspection is non-inferior compared to dye-based chromoendoscopy in Inflammatory Bowel Disease: the randomized controlled HELIOS trial2024 Journal of Crohn s and Colitis conference-abstract Medicine Colorectal Cancer Screening and Detection Open access
Maarten te Groen, Anouk M. Wijnands, Nathan den Broeder, W van Dop, Marjolijn Duijvestein, Herma H. Fidder, +8 more
5citations -
OP0243 SINGLE-CELL RNA SEQUENCING OF ACPA-ENRICHED B CELLS REVEALED A CD11c+ ATYPICAL B CELL GENE SIGNATURE IN RHEUMATOID ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Rheumatoid Arthritis Research and Therapies Open access
Yasuo Nagafuchi, Linda M. Slot, Deimantė Šimaitė, Aleida M. Bakker, Erik B. van den Akker, Tom W. J. Huizinga, +3 more
0citations -
IMAGINATION: A Global Phase 3 Trial of RO7434656, an Antisense Oligonucleotide Inhibitor of Complement Factor B, in IgA Nephropathy2023 Journal of the American Society of Nephrology conference-abstract Medicine Renal Diseases and Glomerulopathies Open access
Jonathan Barratt, Jürgen Floege, Vishal Duggal, Nadine Schmit, Jeannette Lo, Brad H. Rovin
4citations -
MYF3001: A Randomized Open Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed/Refractory to Janus Kinase Inhibitor
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
2citations -
FC058: Long-Term Renal Survival of Anca-Associated Vasculitis Patients Included in the Euvas Randomized Clinical Trials2022 Nephrology Dialysis Transplantation conference-abstract Medicine Vasculitis and related conditions Open access
Beatriz Sánchez Álamo, Laura Moi, Ingeborg M. Bajema, Zdenka Hrušková, David R.W. Jayne, Kerstin W A Westman
1citations -
Abstract 299: From factory to patient: In vivo -expressed biologics as a new paradigm for immunotherapy manufacturing.2026 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery
Dan Rocca, Philipp Tobias Meyer, Ina Rohleff, Eva Oswald, Namrata Jayanth, Christian Wessel Cobaugh, +6 more
0citations -
A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).2025 Journal of Clinical Oncology conference-abstract Medicine Radiopharmaceutical Chemistry and Applications
Andrei H. Iagaru, GIUSEPPE T. CARDACI, Aaron Richard Hansen, Jeffrey Y.C. Wong, Carlos Artigas, Karolien E. Goffin, +7 more
0citations -
The Role of Multisensory Integration and Attention in Sexual Incentive Salience2022 The Journal of Sexual Medicine conference-abstract Psychology Multisensory perception and integration
Gerben B. Ruesink, Tabea M. Zorn, Aleksandra Pawłowska, Swantje M. Borsutzky, Marie-Céline Gerwert, Sander Martens, +1 more
0citations
17 results